Its prognostic value has also been reported in several cancers, as high OX40 expression in the tumor immune infiltrate taken from patients with cutaneous melanoma, colorectal cancer, or non–small cell lung cancer was associated with improved survival (25–27). The gene discussed is TNFRSF4; the disease is cancer.